Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Homcy Charles J
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   1,546,413    

Indirect Shares

   188,122      
Direct Value   $37,508,884    

Indirect Value

   $3,452,400      
Total Shares   1,734,535      
Total Value   $40,961,284      


Geron Corporation $237,826 Portola Pharmaceuticals Inc $2,027,852 Global Blood Therapeutics, Inc. $4,638,691 Bridgebio Pharma, Inc. $30,604,515 Pliant Therapeutics, Inc. $0 Geron Corporation $237,826 Portola Pharmaceuticals Inc $2,027,852 Global Blood Therapeutics, Inc. $4,638,691 Bridgebio Pharma, Inc. $30,604,515 Pliant Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Millennium Pharmaceuticals Inc MLNM Director 2008-05-09 0 2004-02-17 1,119    Premium*  
            Geron Corporation GERN Director 2011-05-11 62,751 2007-01-03 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2019-01-02 112,471 2019-01-02 185,403    Premium*  
            Global Blood Therapeutics, Inc. GBT Director 2017-10-27 67,728 2017-10-27 1,600    Premium*  
            Bridgebio Pharma, Inc. BBIO 2024-02-16 1,230,085 2019-07-01 0    Premium*  
            Pliant Therapeutics, Inc. PLRX Director 2020-06-02 73,378 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BBIO Bridgebio Pharma, Inc.   –       •      –    2024-02-16 4 OE $0.00 $0 D/D 3,760 1,231,594 0 -
BBIO Bridgebio Pharma, Inc.   –       •      –    2024-02-16 4 D $37.21 $56,150 D/D (1,509) 1,230,085 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2023-11-16 4 D $28.86 $37,547 D/D (1,301) 1,226,996 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2023-11-16 4 OE $0.00 $0 D/D 3,760 1,228,297 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2023-08-16 4 D $29.80 $38,770 D/D (1,301) 1,224,537 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2023-08-16 4 OE $0.00 $0 D/D 3,760 1,225,838 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2023-05-16 4 D $14.09 $18,317 D/D (1,300) 1,220,827 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2023-05-16 4 OE $0.00 $0 D/D 3,759 1,222,127 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2023-02-16 4 D $12.64 $19,390 D/D (1,534) 1,218,368 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2023-02-16 4 OE $0.00 $0 D/D 3,760 1,219,902 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2022-11-16 4 D $9.64 $12,542 D/D (1,301) 1,214,251 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2022-11-16 4 OE $0.00 $0 D/D 3,760 1,215,552 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2022-08-16 4 D $11.08 $14,260 D/D (1,287) 1,209,455 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2022-08-16 4 OE $0.00 $0 D/D 3,760 1,210,742 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2022-05-16 4 OE $0.00 $0 D/D 3,759 1,208,523 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2022-05-16 4 D $6.74 $10,386 D/D (1,541) 1,206,982 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2021-03-01 4 D $71.91 $37,681 D/D (524) 1,204,764 0 -
BBIO Bridgebio Pharma, Inc. Director   –       •      –    2021-03-01 4 A $0.00 $0 D/D 1,521 1,205,288 0 -
BBIO Bridgebio Pharma, Inc. Chairman of Pharmaceuticals   •       •      –    2020-10-16 4 AS $41.00 $420,496 D/D (10,256) 1,203,767 0 %
BBIO Bridgebio Pharma, Inc. Chairman of Pharmaceuticals   •       •      –    2020-10-16 4 OE $17.00 $174,352 D/D 10,256 1,214,023 0 -
BBIO Bridgebio Pharma, Inc. Chairman of Pharmaceuticals   •       •      –    2020-09-30 4 OE $17.00 $170,000 D/D 10,000 1,213,767 0 -
BBIO Bridgebio Pharma, Inc. Chairman of Pharmaceuticals   •       •      –    2020-09-30 4 AS $38.00 $380,000 D/D (10,000) 1,203,767 0 %
BBIO Bridgebio Pharma, Inc. Chairman of Pharmaceuticals   •       •      –    2020-09-29 4 AS $37.50 $682,500 D/D (18,200) 1,203,767 0 %
BBIO Bridgebio Pharma, Inc. Chairman of Pharmaceuticals   •       •      –    2020-09-25 4 AS $36.68 $2,985,455 D/D (81,057) 1,221,967 0 %
PLRX Pliant Therapeutics, Inc. Director   –       •      –    2020-06-02 3 IO $0.00 $0 D/D 0 73,378 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us